vs
Astrana Health, Inc.（ASTH）与Fabrinet（FN）财务数据对比。点击上方公司名可切换其他公司
Fabrinet的季度营收约是Astrana Health, Inc.的1.2倍（$1.1B vs $950.5M），Fabrinet净利率更高（9.9% vs 0.7%，领先9.3%），Astrana Health, Inc.同比增速更快（42.9% vs 35.9%），Fabrinet自由现金流更多（$-5.3M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 24.4%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Fabrinet（股票代码FN）为标普中型股400指数成分股。该指数由标普道琼斯指数公司维护，覆盖400家以美企为主的中等市值企业，若成分企业存在多类流通股，指数的成分股总量有时会超过400只。
ASTH vs FN — 直观对比
营收规模更大
FN
是对方的1.2倍
$950.5M
营收增速更快
ASTH
高出7.0%
35.9%
净利率更高
FN
高出9.3%
0.7%
自由现金流更多
FN
多$601.0K
$-6.0M
两年增速更快
ASTH
近两年复合增速
24.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.1B |
| 净利润 | $6.6M | $112.6M |
| 毛利率 | — | 12.2% |
| 营业利润率 | 1.9% | 10.1% |
| 净利率 | 0.7% | 9.9% |
| 营收同比 | 42.9% | 35.9% |
| 净利润同比 | 184.4% | 30.0% |
| 每股收益（稀释后） | $0.12 | $3.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHFN
| Q4 25 | $950.5M | $1.1B | ||
| Q3 25 | $956.0M | $978.1M | ||
| Q2 25 | $654.8M | $909.7M | ||
| Q1 25 | $620.4M | $871.8M | ||
| Q4 24 | $665.2M | $833.6M | ||
| Q3 24 | $478.7M | $804.2M | ||
| Q2 24 | $486.3M | $753.3M | ||
| Q1 24 | $404.4M | $731.5M |
净利润ASTHFN
| Q4 25 | $6.6M | $112.6M | ||
| Q3 25 | $373.0K | $95.9M | ||
| Q2 25 | $9.4M | $87.2M | ||
| Q1 25 | $6.7M | $81.3M | ||
| Q4 24 | $-7.8M | $86.6M | ||
| Q3 24 | $16.1M | $77.4M | ||
| Q2 24 | $19.2M | $81.1M | ||
| Q1 24 | $14.8M | $80.9M |
毛利率ASTHFN
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 12.4% |
营业利润率ASTHFN
| Q4 25 | 1.9% | 10.1% | ||
| Q3 25 | 2.0% | 9.6% | ||
| Q2 25 | 3.1% | 9.8% | ||
| Q1 25 | 3.3% | 9.0% | ||
| Q4 24 | 0.1% | 9.5% | ||
| Q3 24 | 5.9% | 9.6% | ||
| Q2 24 | 6.2% | 9.7% | ||
| Q1 24 | 7.5% | 9.7% |
净利率ASTHFN
| Q4 25 | 0.7% | 9.9% | ||
| Q3 25 | 0.0% | 9.8% | ||
| Q2 25 | 1.4% | 9.6% | ||
| Q1 25 | 1.1% | 9.3% | ||
| Q4 24 | -1.2% | 10.4% | ||
| Q3 24 | 3.4% | 9.6% | ||
| Q2 24 | 3.9% | 10.8% | ||
| Q1 24 | 3.7% | 11.1% |
每股收益（稀释后）ASTHFN
| Q4 25 | $0.12 | $3.11 | ||
| Q3 25 | $0.01 | $2.66 | ||
| Q2 25 | $0.19 | $2.41 | ||
| Q1 25 | $0.14 | $2.25 | ||
| Q4 24 | $-0.14 | $2.38 | ||
| Q3 24 | $0.33 | $2.13 | ||
| Q2 24 | $0.40 | $2.22 | ||
| Q1 24 | $0.31 | $2.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $960.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $2.2B |
| 总资产 | $2.2B | $3.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHFN
| Q4 25 | $429.5M | $960.8M | ||
| Q3 25 | $463.4M | $968.8M | ||
| Q2 25 | $342.1M | $934.2M | ||
| Q1 25 | $260.9M | $950.7M | ||
| Q4 24 | $290.8M | $934.6M | ||
| Q3 24 | $350.3M | $908.9M | ||
| Q2 24 | $327.7M | $858.6M | ||
| Q1 24 | $337.3M | $794.0M |
股东权益ASTHFN
| Q4 25 | $779.3M | $2.2B | ||
| Q3 25 | $775.5M | $2.1B | ||
| Q2 25 | $765.5M | $2.0B | ||
| Q1 25 | $745.4M | $1.9B | ||
| Q4 24 | $712.7M | $1.8B | ||
| Q3 24 | $704.6M | $1.8B | ||
| Q2 24 | $678.9M | $1.7B | ||
| Q1 24 | $653.5M | $1.7B |
总资产ASTHFN
| Q4 25 | $2.2B | $3.3B | ||
| Q3 25 | $2.2B | $3.0B | ||
| Q2 25 | $1.4B | $2.8B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.4B | $2.5B | ||
| Q3 24 | $1.3B | $2.4B | ||
| Q2 24 | $1.3B | $2.3B | ||
| Q1 24 | $1.2B | $2.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $46.3M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-5.3M |
| 自由现金流率自由现金流/营收 | -0.6% | -0.5% |
| 资本支出强度资本支出/营收 | 0.3% | 4.6% |
| 现金转化率经营现金流/净利润 | -0.44× | 0.41× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $102.3M |
8季度趋势，按日历期对齐
经营现金流ASTHFN
| Q4 25 | $-2.9M | $46.3M | ||
| Q3 25 | $10.0M | $102.6M | ||
| Q2 25 | $90.9M | $55.1M | ||
| Q1 25 | $16.6M | $74.2M | ||
| Q4 24 | $-10.9M | $115.9M | ||
| Q3 24 | $34.0M | $83.2M | ||
| Q2 24 | $23.2M | $83.1M | ||
| Q1 24 | $6.0M | $100.9M |
自由现金流ASTHFN
| Q4 25 | $-6.0M | $-5.3M | ||
| Q3 25 | $7.4M | $57.3M | ||
| Q2 25 | $89.5M | $4.7M | ||
| Q1 25 | $13.6M | $45.7M | ||
| Q4 24 | $-13.5M | $94.0M | ||
| Q3 24 | $31.7M | $62.9M | ||
| Q2 24 | $20.4M | $70.4M | ||
| Q1 24 | $5.6M | $87.3M |
自由现金流率ASTHFN
| Q4 25 | -0.6% | -0.5% | ||
| Q3 25 | 0.8% | 5.9% | ||
| Q2 25 | 13.7% | 0.5% | ||
| Q1 25 | 2.2% | 5.2% | ||
| Q4 24 | -2.0% | 11.3% | ||
| Q3 24 | 6.6% | 7.8% | ||
| Q2 24 | 4.2% | 9.3% | ||
| Q1 24 | 1.4% | 11.9% |
资本支出强度ASTHFN
| Q4 25 | 0.3% | 4.6% | ||
| Q3 25 | 0.3% | 4.6% | ||
| Q2 25 | 0.2% | 5.5% | ||
| Q1 25 | 0.5% | 3.3% | ||
| Q4 24 | 0.4% | 2.6% | ||
| Q3 24 | 0.5% | 2.5% | ||
| Q2 24 | 0.6% | 1.7% | ||
| Q1 24 | 0.1% | 1.9% |
现金转化率ASTHFN
| Q4 25 | -0.44× | 0.41× | ||
| Q3 25 | 26.69× | 1.07× | ||
| Q2 25 | 9.65× | 0.63× | ||
| Q1 25 | 2.48× | 0.91× | ||
| Q4 24 | — | 1.34× | ||
| Q3 24 | 2.11× | 1.07× | ||
| Q2 24 | 1.21× | 1.02× | ||
| Q1 24 | 0.40× | 1.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
